Incidence of β-thalassemia carrier on 1495 couples in preconceptional period

Autor: Antonio Malvasi, Elena Pacella, Giancarlo Di Renzo, Antonio Capalbo, Andrea Tinelli, Annunziata Anna Epifania, Domenico Dell’Edera, Maria Brigida Lioi
Rok vydání: 2012
Předmět:
Erythrocyte Indices
Male
Pathology
thalassemia
HbA2 levels
Thalassemia
β-thalassemia carrier
Globular resistance of erythrocytes (GRO)
Hemoglobin subtypes
Blood Cell Count
Fetal Hemoglobin
Hemoglobin A2
Heterozygote Detection
Humans
Italy
Mutation
Osmotic Fragility
beta-Globins
beta-Thalassemia
Preconception Care
Pediatrics
Perinatology and Child Health

Obstetrics and Gynecology
Physiology
Beta globulins
Pediatrics
hemic and lymphatic diseases
Medicine
hba
beta thalassemia
medicine.diagnostic_test
trait
Incidence (epidemiology)
beta globin
Genetic Carrier Screening
globin
hbf
Erythrocyte fragility
Complete blood count
Beta thalassemia
Perinatology and Child Health
medicine.medical_specialty
preconceptional
thalassemia
beta thalassemia
hba
beta
thalassemia trait
preconceptional
gro
couple
trait
mutation
cbc
globin
beta globin
globin gene
hbf

couple
Fetal hemoglobin
gro
cbc
business.industry
globin gene
medicine.disease
thalassemia trait
beta
business
Zdroj: The journal of maternal-fetalneonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 26(5)
ISSN: 1476-4954
Popis: This research, conducted on 1495 couples in preconceptional period, demonstrates how the study of globular resistance of erythrocytes (GRO) is not a first choice test and not useful as other more accurate tests to identify subjects with β-thalassemia trait. Instead, the complete blood count (CBC) and the evaluation of HbA, HbA2 and HbF by high pressure liquid chromatography (HPLC) are essential.Each couple arrived in our laboratory to screen for β thalassemia. In case of patients with positive (240) or doubtful (112) results, we studied β-globin gene.Of the 2990 subjects examined, we found 280 subjects with β-thalassemia trait (9.36%). During biochemical tests, among 112 subjects with doubtful--normal GRO or altered GRO--results, 40 of them resulted positive for the molecular analysis, while 72 of them did not show mutations in β-globin genes. The 2710 samples with non-carriers of β-thalassemia trait presented as mean evaluation of HbA2 2.6%, while the 280 subjects with β-thalassemia trait presented as mean evaluation of HbA2 4.8%. Molecular study showed that the β thalassemia phenotype is caused by a small number of mutations, whose regional distribution is typical.In the presence of thalassemic parameters in the CBC, the accurate and precise quantification of hemoglobin HbA2 is essential for the diagnosis of β-thalassemia trait. DNA mutation analysis provides the most effective way to detect primary gene mutations. The mutations identified in this work can be identified with a simple and inexpensive kit. This means, in economic terms, a significant savings for health spending.
Databáze: OpenAIRE